首页> 外文期刊>British Journal of Clinical Pharmacology >Sustaining and spreading penicillin allergy delabelling: A narrative review of the challenges for service delivery and patient safety
【24h】

Sustaining and spreading penicillin allergy delabelling: A narrative review of the challenges for service delivery and patient safety

机译:维持和传播青霉素过敏制联赛:对服务交付和患者安全挑战的叙述述评

获取原文
获取原文并翻译 | 示例
           

摘要

Many patients report allergies to penicillin, although in over 90% of these the label of penicillin allergy is shown to be incorrect following comprehensive testing. Inappropriate and inaccurate penicillin allergy labelling is a barrier to antimicrobial stewardship and can lead to patient harm. This review assesses an emergent evidence base and trend favouring delabelling using direct oral penicillin challenges following a stratified risk assessment of the likelihood and existence of true penicillin allergy, to identify and make recommendations for key components for implementation in standard practice. Research to date has focussed on the feasibility and clinical and financial outcomes of these direct delabelling strategies. There is a paucity of studies exploring the views and engagement of patients and healthcare professionals, and a gap in the evidence for prerequisites to safely deliver, sustain and spread the implementation of such services across health systems.
机译:许多患者向青霉素报告过敏,尽管在这些超过90%的这些超过90%的青霉素过敏后,综合测试后显示出不正确。 不恰当和不准确的青霉素过敏标签是抗微生物管道的障碍,可以导致患者伤害。 本综述评估了使用直接口服青霉素挑战的急性证据基础和趋势,在对真皮过敏的可能性和存在的分层风险评估之后,识别和提出在标准实践中实施关键部件的建议。 迄今为止的研究侧重于这些直接二选战略的可行性和临床和金融结果。 缺乏研究患者和医疗保健专业人员的观点和参与的研究,以及安全地提供,维持和蔓延在卫生系统上实施此类服务的证据的差距。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号